Stocks losers - Yahoo Finance

UK Markets closed
  • RR.L
    Financial Times6 hours ago

    [$$] UK investigation into Rolls-Royce turns its focus to individuals

    In 2009, Rolls-Royce paid £3.32m to rent a Dubai warehouse for eight months to store defence products destined for the Indian market. The only problem was that, apart from a test run, no Rolls-Royce stock ...

  • Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA
    Zacks12 hours ago

    Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA

    Shire plc (SHPG) announced that the FDA has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for pipeline candidate, SHP465.

  • AZN.L
    Reuters13 hours ago

    Bristol-Myers lung cancer delay slams shares, keeps Merck in lead

    Bristol-Myers Squibb Co (BMY.N) shares fell 11 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its immunotherapy drug combination in first-line lung cancer, further solidifying Merck & Co Inc's (MRK.N) leading position in the burgeoning immuno-oncolgy field. Lung cancer is by far the biggest oncology market and a handful of companies have been battling to become dominant in initial, or first-line, treatment, and to provide much-needed combination therapies. Merck shares rose 3.6 percent to $62.53, while Bristol fell to $49.23.